Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001322955 | SCV001513852 | benign | not provided | 2022-08-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004651585 | SCV005146396 | uncertain significance | Inborn genetic diseases | 2024-04-01 | criteria provided, single submitter | clinical testing | The c.450G>T (p.M150I) alteration is located in exon 8 (coding exon 8) of the NEDD4L gene. This alteration results from a G to T substitution at nucleotide position 450, causing the methionine (M) at amino acid position 150 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003953661 | SCV004766687 | uncertain significance | NEDD4L-related disorder | 2023-10-24 | no assertion criteria provided | clinical testing | The NEDD4L c.450G>T variant is predicted to result in the amino acid substitution p.Met150Ile. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |